Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Conexio

Conexio
2002 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of genetic sequencing and mutation detection products and services. The company has developed and supplied a novel genetic sequencing and mutation detection products and specializes in typing used to match patients and donors for bone marrow or cord blood transplants.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • PO BOX 1294
  • Fremantle, Western Australia 6959
  • Australia

Conexio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Conexio‘s full profile, request access.

Request full access to PitchBook

Conexio Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Conexio‘s full profile, request access.

Request full access to PitchBook

Conexio Executive Team (2)

Name Title Board
Seat
Contact
Info
David Sayer Ph.D Co-Founder & Chief Executive Officer
Damian Goodridge Ph.D Co-Founder, Chief Software Engineer & Lead Software Developer